Common Equity: The sum of all common equity items.
FibroBiologics Inc. (FBLG) had Common Equity of $1.81M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-4.05M |
|
-- |
|
-- |
|
$4.07M |
|
$-4.07M |
|
$0.02M |
|
$-4.05M |
|
$-4.05M |
|
$-4.05M |
|
$-4.05M |
|
$-4.05M |
|
$-4.05M |
|
$-4.07M |
|
$-3.95M |
|
10.59M |
|
10.59M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$4.78M |
|
$0.66M |
|
$1.97M |
|
$6.75M |
|
$3.93M |
|
-- |
|
$1.01M |
|
$4.94M |
|
|
Common Equity |
$1.81M |
$1.81M |
|
$1.81M |
|
8.33M |
|
| Cash Flow Statement Financials | |
$-10.41M |
|
$-0.02M |
|
$6.70M |
|
$4.89M |
|
$1.17M |
|
$-3.73M |
|
$2.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-223.77% |
|
-223.77% |
|
-59.96% |
|
-223.77% |
|
$0.22 |
|
$-0.98 |
|
$-0.98 |
|